Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study

A C K Larstorp, P M Okin, R B Devereux, M H Olsen, H Ibsen, B Dahlöf, Eigil Kjeldsen, K Wachtell

18 Citations (Scopus)

Abstract

The predictive value of changes in the severity of electrocardiographic left ventricular hypertrophy (ECG-LVH) during antihypertensive therapy remains unclear in isolated systolic hypertension (ISH). In a Losartan Intervention For Endpoint reduction in hypertension substudy, we included 1320 patients aged 54-83 years with systolic blood pressure (BP) of 160-200 mm Hg, diastolic BP
Original languageEnglish
JournalJournal of Human Hypertension
Volume25
Issue number3
Pages (from-to)178-85
Number of pages8
ISSN0950-9240
DOIs
Publication statusPublished - 1 Mar 2011

Fingerprint

Dive into the research topics of 'Changes in electrocardiographic left ventricular hypertrophy and risk of major cardiovascular events in isolated systolic hypertension: the LIFE study'. Together they form a unique fingerprint.

Cite this